Last quarter (Q ), Alterity Therapeutics Ltd.'s total revenue was AU$―, a decrease of ― from the same quarter last year. In Q, Alterity Therapeutics Ltd.'s net income was AU$―. See Alterity Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Total Revenue	-	AU$ 3.93M	-	AU$ 0.00	AU$ 0.00	AU$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	AU$ 3.93M	-	-	-	-
Operating Expense	-	AU$ 18.57M	AU$ 20.26M	AU$ 14.74M	AU$ 13.47M	AU$ 17.42M
Operating Income	-	AU$ -14.64M	AU$ -20.26M	AU$ -14.74M	AU$ -13.47M	AU$ -17.42M
Net Non Operating Interest Income Expense	-	AU$ 16.44K	AU$ 2.50K	AU$ 20.68K	AU$ 17.12K	AU$ 108.54K
Other Income Expense	-	-	AU$ -4.76M	AU$ -591.34K	AU$ -7.85K	AU$ 4.98M
Pretax Income	-	AU$ -13.70M	AU$ -12.78M	AU$ -15.31M	AU$ -13.46M	AU$ -12.34M
Tax Provision	-	AU$ 104.46K	AU$ 70.01K	AU$ 0.00	AU$ 0.00	AU$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	AU$ -13.81M	AU$ -12.85M	AU$ -15.31M	AU$ -13.46M	AU$ -12.34M
Basic EPS	-	-	-	AU$ >-0.01	AU$ -0.01	AU$ -0.02
Diluted EPS	-	-	-	AU$ >-0.01	AU$ -0.01	AU$ -0.02
Basic Average Shares	-	-	-	AU$ 1.70B	AU$ 894.87M	AU$ 615.77M
Diluted Average Shares	-	-	-	AU$ 1.70B	AU$ 894.87M	AU$ 615.77M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	AU$ 87.61K	AU$ 72.76K	AU$ 132.84K
Total Expenses	-	AU$ 18.57M	AU$ 20.26M	AU$ 14.74M	AU$ 13.47M	AU$ 17.42M
Net Income From Continuing And Discontinued Operation	-	AU$ -13.81M	AU$ -12.85M	AU$ -15.31M	AU$ -13.46M	AU$ -12.34M
Normalized Income	-	-	-	AU$ -15.08M	AU$ -13.80M	AU$ -12.69M
Interest Expense	-	-	-	-	-	-
EBIT	-	-	AU$ -12.78M	AU$ -14.74M	AU$ -13.47M	AU$ -17.42M
EBITDA	-	-	AU$ -12.78M	AU$ -14.66M	AU$ -13.35M	AU$ -17.39M

Currency in AUD

Alterity Therapeutics Ltd. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing